METTL3 and hepatocellular carcinoma: Moreover, Lin et al. revealed a critical function for METTL3-mediated m6A modification in the hypoxic tumor microenvironment and identifies FOXO3 as an important target of m6A modification in the resistance of HCC to sorafenib therapy 18.